Roger Mills
Patrimonio netto: 39 362 $ in data 30/06/2026
Patrimonio netto: 39 362 $ in data 30/06/2026
Dr. Roger G.
Mills, MD, is a Non-Executive Director & Chief Medical Officer at Addex Therapeutics Ltd. and a Director & Executive Vice President at San Diego Opera.
He is on the Board of Directors at Enterin, Inc., Addex Therapeutics Ltd. and San Diego Opera.
Dr. Mills was previously employed as a Chief Medical Officer & Executive VP-Development by ACADIA Pharmaceuticals, Inc., a Principal by Gilead Sciences, Inc., a Vice President-Development by Pfizer (St. Louis), and a Principal by Wellcome Foundation Ltd. He received his doctorate degree from Charing Cross Hospital Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 785.976 ( 0,36% ) | 39 362 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Direttore Tecnico/Scientifico/R&S | 28/11/2016 |
San Diego Opera
San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Direttore/Membro del Consiglio | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Direttore/Membro del Consiglio | 13/09/2021 |
| Società | Posizione | Fine |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 04/11/2015 |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | - |
Wellcome Foundation Ltd
Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Wellcome Foundation Ltd
Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Commercial Services |
Addex Therapeutics Ltd.
Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
San Diego Opera
San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Consumer Services |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Health Technology |
Charing Cross Hospital Medical School
Charing Cross Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale